Novel schistosomiasis vaccine: New phase of clinical studies
A novel schistosomiasis vaccine called Sm14 Vaccine has reached phase II clinical studies, prioritized by the World Health Organization. The vaccine aims to prevent the parasite that causes the disease from installing in the patient's organism and causing damage.